|
|
|
India News Releases
|
(India.CityRegions.Com, June 09, 2017 ) Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles and untreated sleep apnea. Treatment includes hormone replacement.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Male Hypogonadism - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Male Hypogonadism (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 3, 1, 4, 7, 2, 1 and 5 respectively. Similarly, the Universities portfolio in Phase II stages comprises 1 molecules, respectively.
Male Hypogonadism (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/male-hypogonadism-pipeline-review-h1-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Male Hypogonadism (Male Health).
- The pipeline guide reviews pipeline therapeutics for Male Hypogonadism (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Male Hypogonadism (Male Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Male Hypogonadism (Male Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Male Hypogonadism (Male Health)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001689457/sample
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Male Hypogonadism (Male Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Male Hypogonadism (Male Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Antares Pharma Inc
Clarus Therapeutics Inc
EndoCeutics Inc
Ferring International Center SA
IASO BioMed Inc
Lipocine Inc
M et P Pharma AG
Medlab Clinical Ltd
Merck & Co Inc
Mereo Biopharma Group Plc
Pantarhei Bioscience BV
Repros Therapeutics Inc
Takeda Pharmaceutical Company Ltd
TesoRx Pharma LLC
Viramal Ltd
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001689457/discount
List of Tables
Number of Products under Development for Male Hypogonadism, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Male Hypogonadism - Pipeline by Antares Pharma Inc, H1 2017
Male Hypogonadism - Pipeline by Clarus Therapeutics Inc, H1 2017
Male Hypogonadism - Pipeline by EndoCeutics Inc, H1 2017
Male Hypogonadism - Pipeline by Ferring International Center SA, H1 2017
Male Hypogonadism - Pipeline by IASO BioMed Inc, H1 2017
Male Hypogonadism - Pipeline by Lipocine Inc, H1 2017
Male Hypogonadism - Pipeline by M et P Pharma AG, H1 2017
Male Hypogonadism - Pipeline by Medlab Clinical Ltd, H1 2017
Male Hypogonadism - Pipeline by Merck & Co Inc, H1 2017
Male Hypogonadism - Pipeline by Mereo Biopharma Group Plc, H1 2017
Male Hypogonadism - Pipeline by Pantarhei Bioscience BV, H1 2017
Male Hypogonadism - Pipeline by Repros Therapeutics Inc, H1 2017
Male Hypogonadism - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
Male Hypogonadism - Pipeline by TesoRx Pharma LLC, H1 2017
Male Hypogonadism - Pipeline by Viramal Ltd, H1 2017
Male Hypogonadism - Dormant Projects, H1 2017
Male Hypogonadism - Discontinued Products, H1 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001689457/buy/2000
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
|
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India.
Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
|
India Business News by Major Cities
|
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|
